Name: Pefloxacin Mesylate Dihydrate
Price: 184.00 USD

- Overview
  - Pefloxacin Mesylate Dihydrate is a broad-spectrum, synthetic, third-generation fluoroquinolone antibiotic. Pefloxacin, an analog of Norfloxacin, was discovered in 1979. Pefloxacin, like other fluoroquinolones, inhibits bacterial DNA gyrase and Topoisomerase IV, which disrupts bacterial cell division. Novel derivatives of Pefloxacin were found to have anti-cancer properties. Quinolone-topoisomerase biology is a useful model to understand host-parasite interactions and investigate manipulation of the bacterial chromosome by topoisomerases.
    Pefloxacin Mesylate Dihydrate is freely soluble in aqueous solution.
    
    Please contact us at for specific academic pricing.
    
    Background
    
    Fluoroquinolone antibiotics like Pefloxacin target bacterial DNA gyrase, a type II topoisomerase enzyme which reduces DNA strain during replication. Because DNA gyrase is required during DNA replication, subsequent DNA synthesis and ultimately cell division is inhibited. This enzyme is the primary target for Gram-negative bacteria.
    Pefloxacin inhibits topoisomerase IV, the primary target for Gram-positive bacteria. Since this enzyme is required to separate replicated DNA, the inhibition results in strand breakage of the bacterial chromosome, which ultimately inhibits DNA replication and transcription.
- Properties
  - CAS Number
    
    149676-40-4
    
    Molecular Formula
    
    C17H20FN3O3 · CH4O3S •2H2O
    
    Molecular Weight
    
    465.49
    
    Appearance
    
    Cream colored powder
    
    Solubility
    
    Freely soluble in water
    
    Other Properties
    
    Source: Synthetic
    PH: 3.5-4.5
    Assay: ≥99.0%
    Loss on Drying: ≤8.5%
    Melting Point: 271°C
    Purity Level: ≥ 99%
    
    Storage
    
    2-8°C
    
    * For research use only
- Applications
  - Application Description
    
    Spectrum: Pefloxacin is a broad-spectrum antibiotic which targets a wide range of Gram-positive and Gram-negative organisms including a few Mycoplasma species such as M. bovis, M. tuberculosis, and M. africanum.
    
    Microbiology Applications: Pefloxacin is commonly used in clinical in vitro microbiological antimicrobial susceptibility tests (panels, discs, and MIC strips) against Gram- positive, Gram-negative, and Mycoplasma microbial isolates. Medical microbiologists use AST results to recommend antibiotic treatment options.
    Representative MIC values include:
    Helicobacter pylori 1 µg/mL - 8 µg/mL
    Mycoplasma bovis 8 µg/mL
    
    Eukaryotic Cell Culture Applications: Pefloxacin cytotoxicity in primary cultures of rat hepatocytes was evaluated and found to be hepatoxic at 400 mg/L (Nordmann et al, 1989). An investigation of Pefloxacin on human myelopoiesis in vitro was evaluated on cell cultures of mononuclear cells derived from human bone marrow samples and found it has no influence on the proliferation of human myeloid precursors at 0.5-50 µg/ml (Pallavicini et al, 1989).
    
    Cancer Applications: The in vitro effect of Pefloxacin on growth of normal hematopoietic progenitor stem cells and on leukemic cell lines was investigated. It was found to have a dose-dependent inhibition of colony formation both from normal bone marrow cells and from the leukemic line K-562 cells and HL-60 cells when used at ≥ 25 µg/ml (Somekh et al, 1989).
    An evaluation of Pefloxacin derivatives and their biological activity was screened against human Pc-3 cancer cell lines and the compounds demonstrated anti-cancer properties (Allaka et al, 2016).